Vivera Pharmaceuticals Supports Naomi Osaka’s Stance On Prioritizing Mental Health
NEWPORT BEACH, Calif. – Vivera Pharmaceuticals, Inc., an innovative, science-driven pharmaceutical company founded on the belief that patients should always come first, recognizes that mental health is important for everyone—including professional athletes. According to the National Institute of Mental Health, one in five adults in the U.S. suffer from mental health-related conditions, a number exacerbated in […]
How Does Chronic Opioid Use Affect the Brain?
Opioids are a class of drugs that work by binding the opioid receptors in the central nervous system. Opioids fall into three categories: prescription opioids, heroin, and synthetic opioids. Due to the way opioids interact with the brain, they can have serious side effects. Unfortunately, these risks only increase the longer a person takes them. Over […]
Heroin and its Role in the Opioid Crisis
The opioid epidemic refers to the three distinct waves of opioid-related overdose deaths, beginning in the 1990s with the over-prescription of pain medications. To help curb the problem, law enforcement and the medical community began trying to control the over-prescription of opioids. As a result, those who were already dependent on these medications started seeking […]
Vivera Pharmaceuticals Congratulates Partner Clinical Research Organization, Parexel International, on $8.5 Billion Acquisition by Goldman Sachs
NEWPORT BEACH, Calif. – Vivera Pharmaceuticals, Inc., congratulates its clinical research partner, Parexel International, on its $8.5 billion acquisition. The EQT IX fund and the private equity business within Goldman Sachs Asset Management recently agreed to purchase the clinical research organization and biopharmaceutical company. Parexel is a leading global provider of clinical research and consulting […]
The Causes and Signs of Opioid Addiction
Opioid addiction is a chronic, life-long disease characterized by a compulsive desire to seek and use opioids, regardless of any negative consequences. Like all addictions, opioid addiction is considered a brain disorder because it involves physical and psychological changes in the brain. If left untreated, addiction can seriously affect a person’s overall health and well-being. By […]
5 Harm Reduction Strategies for Opioid Use Disorder
There are many misconceptions regarding harm reduction strategies for opioid use disorder (OUD), such as the assumption that they deny the dangers of drugs and encourage their use. Instead, harm reduction recognizes that people will use drugs, regardless of their risks, and incorporates ways to reduce their negative consequences. Harm reduction recognizes that people will […]
Vivera Pharmaceuticals Partners with Areum Bio LLC and Access Bio, Inc. to Expand the National Distribution of Emergency Use Authorized COVID-19 Rapid Tests
NEWPORT BEACH, Calif. – Vivera Pharmaceuticals, Inc. and diagnostic testing distributor, Areum Bio LLC, today announce their channel partnership to expand the distribution of Access Bio, Inc.’s CareStart™ COVID-19 Rapid Antigen Test and line of products granted FDA Emergency Use Authorization (EUA). Areum Bio is already a major distributor of New Jersey manufacturer, Access Bio’s CareStart™ […]
Vivera Pharmaceuticals Welcomes Gonçalo Leal to Neurosciences Division as Scientific Advisor
NEWPORT BEACH, Calif. – Vivera Pharmaceuticals, Inc., is pleased to welcome Mr. Gonçalo Leal to the Scientific Advisory Board of the Company’s Neurosciences Division. With 15 years of targeted research and education in the treatment of fluency disorders, Mr. Leal’s experience compliments Vivera’s goal of adding innovative new treatment options for enhanced speech fluency. As Founder […]
Vivera Pharmaceuticals Names Dr. Bobby W. Sandage, Jr. to Company’s Board of Advisors
Esteemed pharmaceutical expert joins innovative Newport Beach pharmaceutical companyin pursuit of breakthrough medical developments NEWPORT BEACH, Calif. – Vivera Pharmaceuticals, Inc., an innovative, science-driven pharmaceutical company, has welcomed Dr. Bobby W. Sandage, Jr. to the Company’s Board of Advisors. With nearly four decades of pharmaceutical experience in drug development, regulatory affairs and life sciences venture […]
Opioid Use Order: The Basics
Did you know that between eight and 12 percent of people who are prescribed opioids for chronic pain develop an opioid use disorder? Between 8 and 12 percent of people who are prescribed opioids develop opioid use disorder. Tweet Since opioids activate the reward system in the brain, many people misuse their prescriptions in order to try […]
